- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05497947
Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy (SOAL-VF)
August 28, 2023 updated by: Centre Hospitalier de Valence
A monocentric study to evaluate the french translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) after Total PharyngoLaryngectomy
Study Overview
Status
Completed
Conditions
Detailed Description
the SOAL questionnaire is a validated Patient Reported Outcomes (PRO) questionnaire in English language.
The aim of this study is to develop a new tool in french language and to evaluate incidence and the specific impact of swallowing disorders on the quality of life of patients after Total PharyngoLaryngectomy.
Study Type
Observational
Enrollment (Actual)
225
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sandrine Beauchard, Msc
- Phone Number: +33475818870
- Email: sbeauchard@ch-valence.fr
Study Locations
-
-
Drome
-
Valence, Drome, France, 26953
- Ch Valence
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients treated by Total PharyngoLaryngectomy in CH Valence
Description
Inclusion Criteria:
- Total PharyngoLaryngectomy
- Age ≥ 18 years old
- Read, write and understand the French language
Exclusion Criteria:
- Patient under guardianship, deprived of liberty, safeguard of justice
- Refusal to participate in research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SOAL- VF
Time Frame: up to 6 months
|
Patient reported outcome measure
|
up to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guillaume BUIRET, MD, Ch Valence
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 3, 2021
Primary Completion (Actual)
July 5, 2022
Study Completion (Actual)
July 3, 2023
Study Registration Dates
First Submitted
August 10, 2022
First Submitted That Met QC Criteria
August 10, 2022
First Posted (Actual)
August 11, 2022
Study Record Updates
Last Update Posted (Actual)
August 29, 2023
Last Update Submitted That Met QC Criteria
August 28, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Respiratory Tract Diseases
- Neoplasms
- Neoplasms by Site
- Gastrointestinal Diseases
- Respiratory Tract Neoplasms
- Otorhinolaryngologic Neoplasms
- Head and Neck Neoplasms
- Pharyngeal Diseases
- Stomatognathic Diseases
- Otorhinolaryngologic Diseases
- Esophageal Diseases
- Laryngeal Diseases
- Deglutition Disorders
- Laryngeal Neoplasms
- Pharyngeal Neoplasms
Other Study ID Numbers
- 0007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Larynx Cancer
-
University of Texas Southwestern Medical CenterCompletedEarly-stage Glottic Larynx CancerUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedLarynx | Larynx Cancer | Neck Cancer | NeckItaly
-
Latin American Cooperative Oncology GroupMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of LarynxBrazil
-
Groupe Oncologie Radiotherapie Tete et CouTumor Study Group Head and NeckCompletedLarynx Cancer | Hypopharynx CancerFrance
-
Mayo ClinicEnrolling by invitationLarynx | Larynx Disease | Laryngectomy | Larynx Stenosis | Larynx FractureUnited States
-
Groupe Oncologie Radiotherapie Tete et CouSanofiCompletedLarynx Cancer | Hypopharynx CancerFrance
-
Hacettepe UniversityCompletedLarynx Cancer | Larynx CarcinomaTurkey
-
National Cancer Institute, EgyptCairo UniversityRecruitingLarynx Cancer Stage I | Glottic CarcinomaEgypt
-
University of LeipzigUniversity of Kiel; University of Cologne; University of Jena; Technical University... and other collaboratorsNot yet recruitingLaryngeal Cancer | Squamous Cell Carcinoma of Head and Neck | Laryngeal Neoplasms | Squamous Cell Carcinoma of the Larynx | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Laryngectomy; Status | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of the Larynx Stage... and other conditions
-
Mansoura UniversityCompletedTotal Laryngectomy | Cancer LarynxEgypt